Yokohama University of Pharmacy RNA Biology Group Hidenori Tani

How long does
an RNA live?

Inside a cell, every RNA is made and then destroyed. We measure that time axis and use it to work out what long noncoding RNAs actually do — and how to turn them into medicines for diseases that have had none.

1.00.50.0 half-life Time → N / N₀

Exponential decay. The time it takes to fall by half is the half-life.
In 2012 we built BRIC-seq to measure it genome-wide.

Built up by
the research group.

49Original articles
24Reviews
2,323Citations
23h-index
19Invited talks
6Awards

Citation metrics from Google Scholar, 20 July 2026.

Research

Three places
we measure time.

01

Liver disease

Human and mouse genomes are about 99% identical, yet lncRNA expression and function diverge between them. That gap is our handle on what lncRNAs do in the liver.

02

Brain disease

Alzheimer's, Parkinson's, epilepsy. Some lncRNAs governing neural development are conserved across species, and we follow their dynamics in living tissue.

03

Machine learning

Large datasets hide patterns a person will miss. We predict interactions between lncRNAs and RNA-binding proteins to surface relationships nobody has reported.

lncRNA

RNA that never
becomes protein.

Longer than 200 nucleotides, never translated — and still running everything from gene expression to cell fate.

Schematic of lncRNA mechanisms: epigenetic apparatus, transcriptional regulation, chromosomal looping, spliceosome assembly, and control of protein stability.

Figure from Cancer Gene Therapy, vol. 29, pp. 1866–1877 (2022)

Since HOTAIR was found in 2007, this field has not stopped surprising us. HOTAIR carries epigenetic control, NEAT1 builds and maintains paraspeckles, and MALAT1 acts on transcription and splicing.

Tens of thousands of lncRNAs are thought to exist. We work out their functions one at a time, map them onto disease, identify new therapeutic targets, and design drugs around the properties only lncRNAs have.

2026

Eight months
of output.

Twelve papers from the group.

  1. 2026.08.26

    Molecular Genetics and Genomics

    Codon optimality predicts mRNA half-life but does not transfer to lncRNAs

    ArticleIF 2.2
  2. 2026.08.25

    WIREs RNA

    The Hypothesis-Driven Loop: An Integrated Dry–Wet Framework for Long Noncoding RNA Functional Analysis

    ReviewIF 4.4
  3. 2026.08.20

    Biotechnology Advances

    Confound-aware lncRNA genomics: Separating biology from abundance, composition, and temporal artefacts

    ReviewIF 14.1
  4. 2026.08.19

    Brain Research

    A replicated astrocyte long non-coding RNA signature of Alzheimer's disease is inverted in amyotrophic lateral sclerosis

    ArticleIF 3.2
  5. 2026.08.18

    Gene

    RNA decay rate as a control point for long non-coding RNA function: a BRIC-based causal analysis of NEAT1

    ArticleIF 2.9
  6. 2026.08.13

    Molecular Genetics and Genomics

    Subcellular localization of human long non-coding RNAs is an isoform-resolved property masked by gene-level analysis

    ArticleIF 2.2
  7. 2026.07.24

    Functional & Integrative Genomics

    A single-cell cell-of-origin audit of the lncRNA RMST

    ArticleIF 4.0
  8. 2026.07.09

    Journal of Molecular Biology

    The Half-Life of a Mark: Dwell Time and the Missing Time Axis of the Epitranscriptome

    ReviewIF 4.7
  9. 2026.07.03

    IUBMB Life

    Half-life as a therapeutic design axis: targeting short-lived lncRNAs with antisense oligonucleotides

    ReviewIF 3.2
  10. 2026.07.01

    Trends in Genetics

    A blind spot in lncRNA discovery

    ReviewIF 12.9
  11. 2026.06.21

    International Journal of Molecular Sciences

    RNA-Binding Protein Occupancy Composition Predicts Long Noncoding RNA Subcellular Localization.

    ArticleIF 5.6
  12. 2026.06.11

    BBA – Gene Regulatory Mechanisms

    Short-lived versus long-lived lncRNAs: RNA stability as a determinant of regulatory function

    ReviewIF 3.6

See every publication

Hidenori Tani, Ph.D.

Building the tools
that do the measuring.

Portrait of Hidenori Tani
Hidenori Tani, Ph.D.

As a fourth-year undergraduate in Satoshi Tsuneda's laboratory, I began research under Dr. Naohiro Noda at AIST. I was handed a problem three Ph.D. holders had spent six months on, and solved it with an idea that arrived on the walk home from a park. That became ABC-PCR, and it is when I decided to be a scientist.

In Nobuyoshi Akimitsu's laboratory at the University of Tokyo, I developed BRIC-seq and measured the decay rates of long noncoding RNAs genome-wide. That time axis has been at the centre of the work ever since.

At AIST I studied lncRNAs in human iPS cells. When COVID-19 arrived I added computational analysis to the wet-lab work. Since 2023 I have been at Yokohama University of Pharmacy, combining both with students.

2008
Ph.D. in Engineering, Waseda University — completed one year early
2009–2012
JSPS Research Fellow (PD), Akimitsu Laboratory, The University of Tokyo
2012–2023
AIST — Researcher, then Senior Researcher
2023–
Associate Professor, Yokohama University of Pharmacy
Awards
JSAC Award for Young Scientists (2018) · RNA Frontier Meeting Best Presentation (2010) · Mizuno Award (2008) · Kenji Koga Prize (2005)

Books

The same questions,
in book form.

Half-lives, decay, and the way time works on living things — written for readers outside the lab.

See every title

Let's collaborate.

601 Matano, Totsuka, Yokohama 245-0066, Japan
Yokohama University of Pharmacy

Get in touch